Challenge intractable blood diseases with advanced clinical techniques
We provide the best medical care for blood diseases requiring high expertise as well as promote the development of new diagnostic and therapeutic techniques.
Our department has four dispensaries, 38 beds for inpatients, and 10 to 15 staff always on duty to provide expert medical care. Every effort is made to develop new diagnostic and therapeutic techniques and to conduct high-quality clinical research to establish evidence based medicine (EBM).
![]() |
![]() |
![]() |
We provide medical care to patients with hematological disorders including malignant diseases, such as leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes (MDS), benign disease, such as aplastic anemia and hemolytic anemia, and coagulation disorders such as hemophilia and von Willebrand disease.
In the therapeutic field of hematological malignancies, we provide the best possible treatment based on informed consent consisting mainly of standard chemotherapies. In addition, we are actively involved in clinical studies and the development of new therapies such as molecular targeting therapies, and the development of new hematopoietic stem cell transplantation processes and immuno-cell therapy.
We aim to provide medical care of the highest quality, safety and satisfaction. We accepted more than 80 new patients with hematological malig-nancies, performed 21 hematopoietic stem cell transplantations, 17 chimeric antigen receptor (CAR) T-cell therapies, and provided medical care to more than 400 patients with congenital hemorrhagic diseases in 2022.
We provide medical care at the "specialized outpatient hemophilia clinic," which is responsible for comprehensive medical care for patients with hemorrhagic disease such as hemophilia and von Willebrand disease, at "long-term follow-up program" for transplant patients, and at "transplant donor clinic" for hematopoietic stem cell transplant donors.
Our department is involved in basic research on topics such as molecular mechanisms of hematological diseases, and in the development of a wide range of advanced clinical techniques including molecular targeting therapies, clinical application of transplantation, regenerative medicine and cell therapy, and control of thrombosis.